Related Experiment Videos

Hormones and the heart: controversies and conundrums

Lorraine A Fitzpatrick

The Journal of Clinical Endocrinology and Metabolism

|December 13, 2003

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Erratum for Abaloparatide in Postmenopausal Women With Osteoporosis and Type 2 Diabetes: A Post Hoc Analysis of the ACTIVE Study.

JBMR plus·2021

Abaloparatide: an anabolic treatment to reduce fracture risk in postmenopausal women with osteoporosis.

Current medical research and opinion·2020

Abaloparatide followed by alendronate in women ≥80 years with osteoporosis: post hoc analysis of ACTIVExtend.

Menopause (New York, N.Y.)·2020

Abaloparatide in Postmenopausal Women With Osteoporosis and Type 2 Diabetes: A Post Hoc Analysis of the ACTIVE Study.

JBMR plus·2020

Cost-effectiveness of sequential treatment with abaloparatide followed by alendronate vs. alendronate monotherapy in women at increased risk of fracture: A US payer perspective.

Seminars in arthritis and rheumatism·2020

Response rates for hip, femoral neck, and lumbar spine bone mineral density in patients treated with abaloparatide followed by alendronate: Results from phase 3 ACTIVExtend.

Bone reports·2019

See all related articles